Related Experiment Video
Updated: Jul 10, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
Published on: March 30, 2022
A novel series of highly selective inhibitors of MMP-3
Gavin A Whitlock1, Kevin N Dack, Roger P Dickinson
1Sandwich Chemistry Department, Pfizer Global Research and Development, Sandwich Labs, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK. gavin.whitlock@pfizer.com
Abstract:
The design and synthesis of a series of highly selective hydroxamate inhibitors of stromelysin-1 (MMP-3) is described. Substitution of a 4-biaryl piperidine sulfonamide core, which binds at the S1' subsite of MMP-3, was optimised to give potent inhibitors of MMP-3, with greater than 300-fold selectivity over MMP-1, MMP-2, MMP-9 and MMP-14. Compounds 26 and 27 were identified as having the best balance of pharmacology and properties required for topical drug delivery.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
